Bonesupport Holding AB (publ) (BONEX.ST)
Bonesupport Holding AB (publ) operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $215.00, up 1.42% on the session, giving a market capitalisation of $14.08B. Its beta of 0.48 implies it has historically moved less than the broad market.
Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.
Bonesupport Holding AB (publ) is most often compared with the following Healthcare names: